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Smumry The in vitro culture conditions allowing survival and initial proliferation of murine primordial germ
cells from 10.5 days post coitum embryos, which include the use of a murine embryonal fibroblast (STO)
feeder, were applied to 21 human seminomas, composed of tumour cells which are considered as the malignant
counterparts of human primordial germ cells. Cells from 18 seminomas attached poorly to STO, and only a
few survived through day 10. In contrast, three seminomas showed a higher degree of attachment. Two of
them showed initial proliferation and enhanced survival: 30 days for tumour SEI and 25 days for tumour SE3.
Tumour SEI was more extensively studied, using the culture conditions allowing the derivation of pluripotent
embryonic stem cells from 8.5 days post coitum munne primordial germ cells, which include the use of STO
feeder, stem cell factor, leukaemia inhibitory factor and basic fibroblast growth factor. The presence of stem
cell factor was necessary and sufficient for colonies of tumour cells to form during the first 3 days of culture.
While the cell number decreased after day 3 in medium without fetal calf serum, it increased until day 9 in
medium containing fetal calf serum. No reprogramming of SEI cells to pluripotent stem cells was observed.
Our data indicate that seminomas form a tumour population with a heterogeneous in vitro behaviour not
equivalent to that of 8.5-10.5 days post coitum munne primordial germ cells.
Keywords: human seminoma; in vitro culture; proliferation; growth factors
In humans, a unique histological entity of testicular germ cell
tumours of adults (TGCTs) exists, namely seminomas (SEs),
which are composed of tumour cells that are considered to be
the malignant counterpart of human primordial germ cells
(PGCs) (Mostofi et al., 1987). No animal model for these
tumours is known, and they cannot be cultured in vitro for a
prolonged period. To develop an in vitro culture system, we
studied the use of Sertoli cell feeders and observed an
enhanced survival (Berends et al., 1991). Because of the
number of animals repeatedly needed as Sertoli cell donors,
as well as the heterogeneity of the feeder preparations, we
looked for alternatives.
SE cells are indistinguishable from the cells of carcinoma
in situ (CIS), the precursor of all TGCTs (Skakkebzk et al.,
1987), except for their invasive behaviour (Skakkebmk et al.,
1987; Oosterhuis and Looijenga, 1993). Both have morpho-
logical and immunohistochemical similarities to PGCs (Skak-
kebtk et al., 1987; Gondos, 1993), and like PGCs most SEs
express the stem cell factor (SCF) receptor c-Kit (Strohmeyer
et al., 1991; Murty et al., 1992). Therefore, we assumed that
SE cells share microenvironmental requirements with PGCs.
Using a murine embryonal fibroblast (STO) feeder, initial
proliferation and survival up to day 6 has been described for
murine PGCs isolated from 10.5 days post coitum (d.p.c.)
embryos (Donovan et al., 1986). The use of soluble or
membrane-bound stem cell factor (SCF), which has an
important role in gametogenesis (see Witte, 1990, for review),
and/or leukaemia inhibitory factor (LIF), which maintains
the pluripotent phenotype of murine embryonal stem (ES)
cells (Heath, 1992; Hilton, 1992) and embryonal carcinoma
(EC) cells (Brown et al., 1992), allowed enhanced survival
and proliferation (De Felici and Dolci, 1991; Dolci et al.,
1991; Godin et al., 1991; Matsui et al., 1991). Further addi-
tion of basic fibroblast growth factor (bFGF), probably
involved in the regulation of germ cell proliferation (Ueno et
al., 1987; Suzuki et al., 1991), resulted in long-term prolifera-
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tion of murine PGCs (Matsui et al., 1992; Resnick et al.,
1992). Under these conditions, plunrpotent ES cells can be
derived from 8.5 d.p.c. PGCs (Matsui et al., 1992; Resnick et
al., 1992). This is interesting in view of the linear progression
model, which assumes the reprogramming of SE cells to
pluripotent stem cells, subsequently giving rise to embryonic
and/or extraembryonic tissues in non-seminomatous TGCTs
(NS) (Oosterhuis and Looijenga, 1993).
Therefore, we have now studied the survival of cells from
21 primary SEs in co-culture with STO cells. The effect of
SCF, LIF and bFGF on the cells from the SEs with the
longest survival on STO feeder was analysed.
Materials and methods
Tumour handling
Twenty-one orchidectomy specimens from patients suspected
ofhaving a germ cell tumour were collected during surgery in
collaborating hospitals. Macroscopically representative parts
of the tumour and the adjacent normal parenchyma were
partly snap frozen using liquid nitrogen, partly put in
medium A [Dulbecco's modified Eagle medium (DMEM/
F12, with 100 kUI-' penicillin, 100 mg -' streptomycin,
40 mg 1-' gentamycin, 365 mg 1- L-glutamine; Gibco,
Paisley, UK] and taken to the laboratory for further process-
ing. Fresh representative samples of all components were
used for imprints and subsequently fixed in 4% formalin
(J.T. Baker, Deventer, The Netherlands) for paraffin embed-
ding. After imprint and frozen section diagnosis of SEs [using
a haematoxylin and eosin (H&E)-stained slide], the tumour
was mechanically disaggregated at room temperature, using
two crossed scalpel blades. Tissue fragments were allowed to
settle in a SOml tube in 30ml of medium A. The super-
natant, containing almost only single cells (as analysed by
microscopy), was washed twice with medium A and either
directly cultured or cryopreserved. To the cell suspension
10% (final concentration) dimethylsulphoxide (DMSO)
(Merck, Darmstadt, Germany) was added slowly. The
suspension was aliquoted, automatically frozen in a Kryo 10
Series 2 (Planer Biomed, Sunbury-on-Thames, UK) (- 2CWnsgm.I d unmmi e pmINo~ i m ined
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min-' to -5_C, -l1Cmin-' to -40 C, -5Cmin' to
- 160-C) and stored under liquid nitrogen.
Tumour characterisation
Histological typing of the tumours was performed according
to the WHO clasiication (Mostofi, 1980; Mostofi et al.,
1987), aided by immunohistochemistry for the expression of
placental-like alkaline phosphatase (PLAP), z-fetoprotein
(AFP), human chorionic gonadotropin (hCG) (Dako, Glos-
trup, Denmark) and cytokeratins 8 and 18 (Becton Dickin-
son, San Jose, CA, USA) on representative paraffin sections,
while c-Kit expression was immunohistochemicaly detected
on frozen sections. All stainings were carried out using an
immunoperoxidaw technique at room temperature with 3,3'-
diaminobenzdine tetrahydrochlonde (Fluka Chemie, Buchs,
Switzerland) visualsation, as described previously (Ooster-
huis et al., 1989).
Feeders
STO cells were cultured in T25 fiasks (Costar, Cambridge,
MA, USA) at 37C in a humid atmosphere with 5% arbon
dioxide in air, using 5 ml of medium A containing 10% fetal
calf serum (FCS) (Gibco) and subcultured once a week. The
feeders were grown in 0.1% gelatin (Sigma, St Louis, MO,
USA) coated six or 12-well tissue culture plastic plates (Co-
star) or T25 flasks and at confluence treated with 1Oigml1'
mitomycin C (Sigma) for 3 h. After a triple wash with
phosphate-buffered saline (PBS) the feeders were kept in
medium A containing 10% FCS and SE cells were inoculated
on the next day.
Seminma-STO co-cultures
Single-cell suspensions from 21 SEs (coded SEI to SE21)
were seeded onto STO feeder. Two tumours were cultured
using the cryopreserved suspension. Nimeteen tumours were
cuured using fresh cell suspensions, while from nine ofthese
tumours cryopr suspensions were also used. SE cells
were seeded in either a T25 flask (I07cells per flask) or a
six-well plate (5 x 10I cells per well), in respectively 5 and
2ml of medium A with 10% FCS. After overnight incuba-
tion at 34C in a humid atmosphere with 5% carbon dioxide
in air, medium was taken off and half a volume of fresh
medium was given to the culture. The old medium was spun
down at 1000 r.p.m. for 5 min and half the volume was
returned to the culture. Subsequently, half of the medium
was changed every other day.
Seminomaproliferation in thepresence ofgrowthfactors
Feeder-containing six-well plates were seeded with 5 x 10'
cryopr SE cells per well after rapid thawing in a 3TC
water bath (experiments 1, 2 and 3). In experiments I and 2
four wells (referred to as wells 1-4) were inoculated for each
condition, while in experiment 3 wells were inoculated in
duplicte (wells 3 and 4). The wells contained 2ml of medium
A, with or without 10% FCS, with or without 60 ngml-'
human recombinant SCF (provided by Amgen, Thousand
Oaks, CA, USA) (experiments 2 and 3) or a combination of
60ngml'I SCF, lOngml ' human recombinant LIF (pro-
vided by Dr JK Heath, Department of Biochemistry, Univer-
sity of Oxford, UK) and 1 ngml-' human recombinant
bFGF (Gibco) (experiments 1, 2 and 3) (this combination of
growth factors is referred to as SLB). SE cell number and
colony size in wells 3 and 4 were counted on days 3 and 9 in
experiment 1, on days 1, 3 and 9 in experiment 2 and on
days 1, 3 and 6 in experiment 3. Cultures were kept at 34-C
in a humid atmosphere with 5% carbon dioxide in air, while
half of the medium was changed every day.
On day 1 of culture, 10 iM bromodeoxyuridine (BrdU)
(Sigma) was added to wells 1 and 2 in experiments 1 and 2.
After overnight incubation, cultures were fixed at room
temperature in 70% ethanol for 15 min. The bottoms of the
wells were cut into two sections using a hot scalpel blade.
The sections were immunohistochemically stained either for
cytokeratin, using 3,3'-diaminobenzidine tetrahydrochloride
visualisation (Oosterhuis et al., 1989), or for PLAP and
BrdU (Organon Teknika, Boxtel, The Netherlands), using a
double-staining technique according to Hardonk and Harms
(1990). PLAP was stained using an immunoperoxidase with
3-amino-9-ethyl carbazole (Sigma) visualisation, while BrdU
was stained with an immuno alaline phosphatase with fast
blue BB salt (Sigma) visuisation. This procedure was re-
peated for wells 3 and 4 (in all three experiments) after
incubation with BrdU from day 8 to 9.
For all conditions, the cells present in three visual fields at
a 320 x magnificaion were counted, using a Zeiss Axiovert
phase contrast microscope (Zeiss, Germany), equipped with a
Sony charge-coupled device (CCD) camera and screen (Sony,
Japan), to allow evaluation of the observed cells by two
individuals.
Statistical analysis
Welch's t-statistics (Sachs, 1982; Miller, 1986) was used to
analyse the influence of serum and growth factors on SE
colony number and size. Analysis was done for each culture
condition separately, comparing the counts of the fixed time
points, i.e. days 3 and 9 in experiment 1, days 1, 3 and 9 in
experiment 2 and days 1, 3 and 6 in experiment 3. All
calulations were performed using Stata software (release 3;
Stata, Santa Monica, CA, USA).
Redls
Twnour characterisation
Immunohistochemially all 21 tumours, which were located
in the testis, were negative for AFP, while they showed
consistent membranous staining for PLAP and c-Kit. Six
tumours were negative for cytokeratin and hCG. In five
tumours cytokeratin-expressing cells and in three tumours
hCG-positive cells were detected. Seven tumours showed
cytokeratin as well as hCG expression.
Seminoma-STO co-cultures
The cells of all tumours except three (SE1, SE2 and SE3)
showed poor attachment to STO feeder, and only few cells
survived through day 10 (not shown). While fresh and
cryopreserved SE2 cells only showed enhanced attachment,
fresh SEl and SE3 cells also survived for over 24 days.
Cryopreserved SEI cells survived for up to 15 days, while no
cryopreserved suspensions of SE3 were available. In all SEI
and SE3 cultures initial proliferation was observed (not
shown).
Seminomaproliferation in thepresence ofgrowthfactors
Because of the availability of cryopreserved cell suspensions
and the better performance in culture ofSEI, these cells were
used to study the effect of growth factors. Therefore, SEI
cells were cultured on STO feeder in DMEM/F12 with or
without FCS, SCF or SLB. All data shown in the figures and
presented in the text are from experiment 2; experments 1
and 3 yielded essentially similar results.
The morphology of SEl cells on STO feeder, in medium
without FCS and growth factors or medium with FCS and
SLB at day 9 of culture, is shown in Figure 1. In medium
without FCS, feeder quality had morphologically declined
and colonies were absent, while large colonies were present in
medium with FCS. Under FCS-free conditions, SE cells were
found on top ofthe STO cells, while they seemed to sink into
the feeder layer when exposed to FCS-containing medium.
The mean colony size of SEI over time, under the various
conditions, is shown in Figure 2. The mean increases in the
colony number and of the mean colony size for days 1-3Hioo oe-opiit ofseunoa ciiprcOllnaon and swviv
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Figwe 1 Morphology of SEl cells on STO feeder on day 9 of
culture in medium without fetal calf serum (FCS) and growth
factors (a) and in medium with FCS and the combination of stem
cell factor, leukaemia inhibitory factor and basic fibroblast
growth factor (SLB) (b) Only in the presence of FCS and SLB
were colonies of up to 40 cells detected. Scale bar = 30 pm.
(first penrod) and days 3-9 (second period) were calculated.
Under FCS-free conditions, without growth factors, no
change in total cell number was observed during the first
period, while this number decreased during the second period
(data not shown). The colony number significantly (P<0.01)
decreased after day 3 (data not shown). During the entire
experiment the mean colony size was constant (1.2 cells per
colony). The use of SCF or SLB with FCS-free medium
resulted in an increase in total cell number during the first
period and a rapid decrease in this number after day 3 (data
not shown). The colony number was constant until day 3,
but decreased significantly (P<0.01) dunrng the second
period. The mean colony size increased significantly (P<
0.01) until day 3 and decreased significantly (P<0.01) after-
wards. In FCS-free medium no colonies with more than two
cells were detected on day 9, irrespective of the presence of
growth factors. In FCS-containing medium the colony
number was constant throughout the experiment, irrespective
of the presence of growth factors. In the absence of growth
factors, total cell number (not shown) and mean colony size
were constant until day 3 (mean size 1.6 cells per colony).
Both increased during the second period. This increase was
only significant (P<0.01) for the mean colony size (mean
size 2.2 cells per colony at day 9). In the presence of SCF or
SLB, total cell number (not shown) and colony size signifi-
cantly (P<0.05) increased during the whole culture period.
In the presence of SCF, the mean colony size on days 3 and
9 was 2.0 and 3.2 cells per colony respectively, while in the
presence of SLB the mean size was 2.1 and 3.3 cells per
colony respectively. Figure 3 illustrates the range of the
colony sizes under the various conditions on days 1, 3 and 9.
In the absence of FCS and growth factors only colonies of 1
and 2 cells were present on day 9, whereas the use of these
6 7 8 9 10
Fuge 2 Mean size of SEI colonies over time under the various
culture conditions. Results are from experiment 2 as a represen-
tative example. Vertical bars indicate standard errors. The letters
a-e indicate a significant (P<0.Ol in all cases, except for a and e
on day 3 with P<0.05) increase or decrease in mean colony size
as compared with the previous count of the colony size (FCS,
fetal calf serum; GF, growth factor(s); SCF, stem cell factor;
SLB, the combination of stem cell factor, leukaemia inhibitory
factor and basic fibroblast growth factor).
additives resulted in the formation of much larger colonies
(up to> 10 cells per colony) at this time point. Only in the
cultures with SLB were a few colonies of up to 40 cells
detected outside the counted fields.
No obvious morphological and immunohistochemical
(PLAP and cytokeratin expression) changes were identified
during the in vitro culture (not shown).
PLAP staining and BrdU incorporation
The counts of PLAP-positive cells confirmed the data
obtained with morphological phase-contrast detection of SEl
cells in culture. SEI cell cultures were incubated with BrdU
from day 1 to 2 or from day 8 to 9 to detect DNA synthesis.
The percentage of PLAP-positive cells showing BrdU incor-
poration ranged from 10% to 24% on day 2, while 0.4-17%
of the cells were labelled on day 9. No differences were found
for the vanrous culture conditions. On days 2 and 9, cells
with incorporated BrdU were detected in colonies of all
sizes.
We have previously shown (Berends et al., 1991) and
confirmed in the present study that SE cells cultured without
a feeder layer (on tissue culture plastic, in DMEM/F12 con-
taining 10% FCS) die within 3 days (data not shown). This
was also found for the cells (SEl) with the longest survival
on STO feeder, even in the presence of SCF or SLB (not
shown). Therefore, we conclude that SE cells need contact
with a specific matrix, which might be provided by feeder
cells, possibly through interactions of the membrane-bound
form of SCF and the receptor c-Kit, in order to survive and
proliferate. This is supported by the finding of the same
survival of the SEI cells on STO with or without additives
during the first 3 days of culture. Since the results from the
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present study are similar to those reported previously on the
use of Sertoli cell feeders for SE culture (Berends et al.,
1991), we conclude that the homogeneous STO feeders seem
to form a good alternative to the use of Sertoli cell
layers.
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The more extensively studied tumour SEl showed an in-
crease in colony size during the first 3 days of culture on
STO feeder, using both SCF and SLB, irespective of the
presence of FCS. From days 3 to 9 colony size increased in
the presence of FCS alone, or with added SCF or SLB.
Probably because of quality decli (morphological changes)
of STO in FCS-free medium, the number and colony size of
SEI cels decreased from day 3 onwards. Therefore, FCS
seems to be necey to directly support the STO clls, while
its effect on SE cells seems to be indirect and through the
feeder layer.
During the first 3 days of culture, the colony number of
SEl ceDs was constant for all conditions. This indicates that
proliferation of SEI cells, for which the p ce of SCF was
necessary and sufficient, caused the growth of the colonies,
instead of chltering of the cells owing to (enhanced) cell
motility. From day 3 onwards all cultures containing FCS
showed an increase in colony size.
Three SEs (SEl, SE2 and SE3) had a plating efficiency on
STO similar to that found for 8.5 dp.c. murine PGCs (30%)
(Matsui et al., 1992), while two of them (SEl and SE3)
initially proliferated, just like 10.5 d.p.c. murine PGCs
(Donovan et al., 1986). However, 18 of the 21 SEs studied
had a plating efficiency on STO of less than 1%. In spite of
survival ofthe att clls from the SEs to about day 10,
no proliferation was found. Apparently, SEs form a tumour
population with a heterogeneous in vitro behaviour, differing
in attachment to STO feeder cells and subsequent survival
and proliferation. The SE cells with an attachment and initial
proliferation simila to that of 8.5 d.p.c. murine PGCs
showed no reprogrammig to pluripotent stem cells under
any of the conditions appled, as judged by their unhanged
morphology and continued expression of membrane-bound
PLAP. Therefore, we conclude that the differentiation state
of SE cells is not similar to that of 8.5-10.5 d.p.c. PGCs.
However, this does not exclude a lnear progression model
for CIS, SE and NS. The differences in the in vitro behaviour
of SEs and murine PGCs might be related to the crucial role
of the age (d.p.c.) of the latter in the ability to respond to
growth factors: 11.5-12.5 d.p.c. murine PGCs do not pro-
liferate when co-cultured with feeder cells in the presence of
SCF or LIF (De Felici and Dolci, 1991; Matsui et al.,
1991).
The heterogeneity in the in vitro behaviour did not cor-
relate with the expression of the markers hCG and/or cyto-
keratins 8 and 18. The differentiation status ofhuman TGCT
cell lines has recently been described to correlate with the
expression of distinct glycolipids, among others carrying the
stagecific embryonic antigens 1, 3 and 4 (Wenk et al.,
1994). Our preliminary results from an extensive study of the
glycolipid profile of primary human TGCTs, especialy SEs
(RA Olie et al. in preparation), revealed no distinct
differentiation status of SEl, SE2 and SE3 as compared with
the other SEs described here. The SCF receptor c-Kit was
detced on all SEs.
Recently, we found a possible explanation for the aberrant
in vitro behaviour of SE1, SE2 and SE3. From 40 SEs
analysed, including 17 of the 21 tumours described in this
paper, these tumours were the only three containing an
activated N- or K-ras gene (Olie et al., 1994). Intestingly,
suppression of apoptosis by an activated ras gene has been
reported (Arends et al., 1993), and we have indications that
mechanical disociation of SE tissue results in apoptosis of
the tumour cells (RA Olie et al., in preparation). These
indications are in agreement with the findings by Frisch and
Francis (1994), who recently reported on the induction and
abrogation by an activated ras gene of apoptosis by disrup-
tion of cell-matrix interactions. Therefore, we conclude that
a higher degree of attachment, alone or in combination with
enhanced survival and initial proliferation of SE cells in vitro,
might be related to the presence of an activated ras gene,
which possibly interferes with the apoptotic pathway. ras
mutations indicate an unfavourable prognosis in childhood
acute lymphocytic leukaemia (Luibbert et al., 1990) and non-
smalH-cell lung cancer (Slebos et al., 1990; Mitsudomi et al.,
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1991), while an enhanced in vitro proliferative capacity is
reported for adult acute myeloid leukaemia with a poor
prognosis (L6wenberg et al.. 1993). In view of these and our
findings we are currently investigating the prognostic
relevance of the in vitro behaviour and presence of ras muta-
tions in SE.
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